EyePoint Pharmaceuticals's chart data is dated 2026-10-08. Recorded technical signals: Mean reversion. There are 0 published signal records.
EyePoint Pharmaceuticals last closed at $3.46 (+4.22%) on 2026-10-08. Signals today: Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -1.0×. Its overall grade ranks 735 of 738 stocks in Healthcare.
About this company
EyePoint Pharmaceuticals last closed at $3.46 (+4.22%) on 2026-10-08. Signals today: Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 735/738
Valuation grade C
Related stocks
- Aerie PharmaceuticalsCompetitor
안과용 치료제·망막 질환 치료 시장에서 경쟁하던 주요 업체
- Apellis PharmaceuticalsCompetitor
망막 질환 치료제 시장의 경쟁사
- NovartisCompetitor
안과/망막 질환 치료제 분야에서 경쟁하는 글로벌 제약사
About EyePoint Pharmaceuticals
- What technical signals does EyePoint Pharmaceuticals (EYPT) have?
- EyePoint Pharmaceuticals current technical signals: Mean reversion.
- Is EyePoint Pharmaceuticals a cup-and-handle pattern?
- No. EyePoint Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for EyePoint Pharmaceuticals?
- Market cap: $286.44M. Trailing 12 months PER: -1.0×. Latest quarter PBR: 1.80×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about EyePoint Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.